Skip to Content

Join the 'Ovarian Cancer' group to help and get support from people like you.

Ovarian Cancer News

Related terms: Cancer, Ovarian, Cancer, Ovaries

Cancer Survivors Gain From Web-Based Health Care

Posted 13 days ago by Drugs.com

FRIDAY, Feb. 10, 2017 – Online- and phone-based health care offers a number of benefits for cancer survivors, British researchers report. The new study looked at previous research on cancer survivors' experiences with online and phone health contacts – what the researchers call telehealth. The review found that patients liked the flexibility and convenience of this method of staying in touch with their care providers because they could do so in a familiar, comfortable setting and with minimum disruption to their lives. The perceived anonymity of telehealth reduced patients' sense of vulnerability and some said they were more comfortable raising concerns in this setting than in face-to-face appointments. Negative aspects of telehealth mentioned by patients included not being able to meet their health care providers in person, while other patients said they couldn't use the service due ... Read more

Related support groups: Cancer, Prostate Cancer, Lung Cancer, Colorectal Cancer, Non-Small Cell Lung Cancer, Breast Cancer, Metastatic, Brain Tumor, Skin Cancer, Ovarian Cancer, Small Cell Lung Cancer, Cervical Cancer, Bladder Cancer, Stomach Cancer, Head and Neck Cancer, Breast Cancer, Prevention, Testicular Cancer, Breast Cancer - Palliative, Zollinger-Ellison Syndrome, Wilms' Tumor, Solid Tumors

Too Few High-Risk Women Tested for Breast Cancer Gene: Survey

Posted 16 days ago by Drugs.com

TUESDAY, Feb. 7, 2017 – Though testing for two genes that raise breast cancer risk has been around for decades, a new survey finds many high-risk women don't get the test, often because they aren't told to by their doctors. Among women with the highest risk, about eight of 10 said they wanted testing for the BRCA1 and BRCA2 mutations. But, "only about half of them actually got the testing they should get," said study author Dr. Allison Kurian, from Stanford University's School of Medicine. "Genetic cancer testing is not well matched to the medical needs of the patient, to a woman's risk of having a mutation," said Kurian, an associate professor of medicine and of health research and policy. Why the gap? About 56 percent of the high-risk women who were not tested said their doctors did not recommend it, the survey found. In addition to the test itself, genetic counseling can help ... Read more

Related support groups: Breast Cancer, Breast Cancer, Metastatic, Ovarian Cancer, Breast Cancer, Prevention, Breast Cancer - Palliative, Diagnosis and Investigation, Osteolytic Bone Metastases of Breast Cancer

Know the Risks, Warning Signs of Ovarian Cancer

Posted 19 Jan 2017 by Drugs.com

WEDNESDAY, Jan. 18, 2017 – Women need to be aware their risk for ovarian cancer increases with age. Half of all cases affect women age 63 or older, according to specialists at Fox Chase Cancer Center in Philadelphia. However, the center reminds all women to be aware of other risk factors for the disease, as well as common ovarian cancer warning signs, such as: Belly bloating or swelling, Lower belly pain, Back pain, Trouble eating or feeling full quickly, Unexplained weight loss, Pain during sex, Menstrual changes, A change in bathroom habits, such as constipation, diarrhea, or having to urinate very badly or very often. "While these symptoms are common and may be caused by something other than ovarian cancer, I advise women to take them seriously," said Dr. Christina Chu, a Fox Chase gynecologic oncologist. "A woman knows what is normal for her own body. If her symptoms don't seem ... Read more

Related support groups: Birth Control, Contraception, Plan B, Cancer, Emergency Contraception, Mirena, Nexplanon, Sprintec, Provera, NuvaRing, Depo-Provera, Implanon, Urinary Tract Infection, Ortho Tri-Cyclen, Tri-Sprintec, Microgestin Fe 1/20, Yasmin, Loestrin 24 Fe, Plan B One-Step, Ortho Evra

FDA Grants Accelerated Approval to Rubraca (rucaparib) for Advanced Ovarian Cancer

Posted 20 Dec 2016 by Drugs.com

December 19, 2016 – The U.S. Food and Drug Administration today granted accelerated approval to Rubraca (rucaparib) to treat women with a certain type of ovarian cancer. Rubraca is approved for women with advanced ovarian cancer who have been treated with two or more chemotherapies and whose tumors have a specific gene mutation (deleterious BRCA) as identified by an FDA-approved companion diagnostic test. “Today’s approval is another example of the trend we are seeing in developing targeted agents to treat cancers caused by specific mutations in a patient’s genes,” said Richard Pazdur, M.D., director of the Office of Hematology and Oncology Products in the FDA’s Center for Drug Evaluation and Research and acting director of the FDA’s Oncology Center of Excellence. “Women with these gene abnormalities who have tried at least two chemotherapy treatments for their ovarian cancer now have a ... Read more

Related support groups: Ovarian Cancer, Rubraca, Rucaparib

Ovarian Cancer Drug Given Fast-Track Approval

Posted 19 Dec 2016 by Drugs.com

MONDAY, Dec. 19, 2016 – The anti-cancer drug Rubraca (rucaparib) has been granted accelerated approval by the U.S. Food and Drug Administration to treat advanced ovarian cancer. The approval is limited to cases where the cancer is caused by specific gene mutations known as "deleterious BRCA." BRCA genes normally repair damaged DNA and are designed to prevent tumor growth, the agency said Monday in a news release. But mutations in these genes could lead to cancer. Rubraca is designed to inhibit a certain enzyme that's produced by a damaged BRCA gene. More than 22,000 women are projected to be diagnosed with ovarian cancer this year, and more than 14,000 are projected to die from the disease, according to U.S. National Cancer Institute estimates cited by the FDA. The FDA simultaneously approved the FoundationFocus CDxBRCA diagnostic screen. This screen detects the presence of deleterious ... Read more

Related support groups: Ovarian Cancer, Acute Myeloid Leukemia

FDA Approves Avastin (bevacizumab) Plus Chemotherapy for a Specific Type of Advanced Ovarian Cancer

Posted 7 Dec 2016 by Drugs.com

South San Francisco, CA – December 6, 2016 – Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) has approved Avastin (bevacizumab), either in combination with carboplatin and paclitaxel or in combination with carboplatin and gemcitabine chemotherapy, followed by Avastin alone, for the treatment of patients with platinum-sensitive recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer. Women are said to have a ‘platinum-sensitive’ form of the disease if a relapse occurs six months or longer following the last treatment with a platinum-based chemotherapy. “With today’s approval of Avastin plus chemotherapy, women in the U.S. with recurrent, platinum-sensitive ovarian cancer now have a treatment option that showed a survival difference of more than five months compared to chemotherapy al ... Read more

Related support groups: Avastin, Ovarian Cancer, Bevacizumab, Peritoneal Cancer, Fallopian Tube Cancer

Worldwide Cancer Rates Up More Than One-Third in Past Decade: Report

Posted 4 Dec 2016 by Drugs.com

SATURDAY, Dec. 3, 2016 – Cancer cases rose 33 percent worldwide in the past 10 years, a new study shows. In 2015, there were 17.5 million diagnoses and 8.7 million deaths in the world from the disease, the researchers found. The rise in cancer cases was mainly due to population aging and growth, along with changes in age-specific cancer rates, according to the Global Burden of Disease Cancer Collaboration study. The lifetime risk of developing cancer was one in three for men and one in four for women, the researchers said. Prostate cancer was the most common type of cancer in men (1.6 million cases), and tracheal, bronchus and lung cancer was the leading cause of cancer death in men. Breast cancer was the most common cancer for women (2.4 million cases), and the leading cause of cancer death in women. The most common cancers in children were leukemia, other neoplasms, non-Hodgkin ... Read more

Related support groups: Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer, Lymphoma, Melanoma, Skin Cancer, Ovarian Cancer, Cervical Cancer, Head and Neck Cancer, Testicular Cancer, Salivary Gland Cancer, Solid Tumors

'Magic Mushroom' Chemical Eases Cancer Patients' Despair

Posted 1 Dec 2016 by Drugs.com

THURSDAY, Dec. 1, 2016 – Cancer often leaves patients feeling that life has no meaning, a state of mind that psychiatrists call "existential distress." But two new, small studies suggest that an ingredient found in hallucinogenic "magic" mushrooms can dramatically reverse this feeling. A single dose of the man-made drug psilocybin quickly lifted spirits for most cancer patients, and the effect lasted as long as six months for many, the researchers reported. One patient described her experience as "life-changing." "In 2010, I was diagnosed with ovarian cancer," Dinah Bazer, who took part in one of the studies, said during a Wednesday media conference. "Following successful surgery and chemotherapy, I was totally consumed with anxiety and fear of recurrence for over two years," she said. "It was running my life and ruining my life." After taking psilocybin, "I was bathed in God's love, ... Read more

Related support groups: Cancer, Substance Abuse, Ovarian Cancer, Toxic Reactions Incl Drug and Substance Abuse

Does Baby Powder Cause Ovarian Cancer?

Posted 4 Nov 2016 by Drugs.com

FRIDAY, Nov. 4, 2016 – A spate of multimillion-dollar jury verdicts against consumer products giant Johnson & Johnson is shining a light on a long-simmering scientific question: Can baby powder cause ovarian cancer? A jury in St. Louis last month seemed to think so. It awarded more than $70 million to a California woman who said she used Johnson's Baby Powder for decades until her ovarian cancer diagnosis. This follows two other jury verdicts in St. Louis this year with similar awards. Currently, there are roughly 1,700 state and federal lawsuits alleging that Johnson & Johnson failed to warn the public of research linking talc-containing powders to ovarian cancer. "We deeply sympathize with the women and families impacted by ovarian cancer," Carol Goodrich, a spokeswoman for the company's consumer products unit, said in a statement. However, Johnson & Johnson maintains that its baby ... Read more

Related support groups: Ovarian Cancer, Diagnosis and Investigation, Sclerosol, Talc, Sterile Powder

Health Highlights: Oct. 29, 2016

Posted 30 Oct 2016 by Drugs.com

Here are some of the latest health and medical news developments, compiled by the editors of HealthDay: First Baby With Zika-Linked Microcephaly Born in Puerto Rico The first baby born with Zika-linked microcephaly has been born in Puerto Rico, health officials there said Friday. Born within the past two weeks, the newborn suffered severe birth defects and is still in the hospital, the Associated Press reported. Microcephaly, a birth defect where a baby is born with an abnormally small head and underdeveloped brain, was not detected in the fetus until the eighth month of pregnancy. The infant also has hearing and vision problems, Dr. Ana Rius, Puerto Rico's Secretary of Health, told the wire service. Authorities are investigating why the case was identified so late although the mother showed Zika symptoms in the first trimester of her pregnancy, Rius told the AP. She added that the ... Read more

Related support groups: Diarrhea, Gas, Gastrointestinal Disorders, Ovarian Cancer, Zika Virus Infection

Know Your Risk for Ovarian Cancer -- and the Symptoms

Posted 9 Sep 2016 by Drugs.com

FRIDAY, Sept. 9, 2016 – A major shift is needed in the prevention and treatment of ovarian cancer, according to a doctor who specializes in the disease. "Ovarian cancer is often diagnosed too late," said Dr. David Fishman, director of the cancer center and gynecologic oncology at NewYork-Presbyterian/Queens. "It's important for women to know their risk [of] contracting this deadly disease, and its earliest warning signs," he added. All women are at risk of ovarian cancer, and one in 75 will develop the disease, Fishman said. More than 250,000 women worldwide are diagnosed with ovarian cancer every year, and 140,000 die from it. Fishman stressed that a clean pap test does not mean a woman's ovaries are cancer-free. Pap tests diagnose cervical disease, not ovarian cancer. Some call ovarian cancer a "silent" killer. Its early symptoms are mild and easy to ignore, according to Fishman. ... Read more

Related support groups: Birth Control, Contraception, Breast Cancer, Polycystic Ovary Syndrome, Ovarian Cysts, Ovarian Cancer

FDA Warns Ovarian Cancer Tests Not Reliable

Posted 9 Sep 2016 by Drugs.com

FRIDAY, Sept. 9, 2016 – Screening tests for ovarian cancer are not reliable and should not be used, the U.S. Food and Drug Administration warns. "Despite extensive research and published studies, there are currently no screening tests for ovarian cancer that are sensitive enough to reliably screen for ovarian cancer without a high number of inaccurate results," the agency said in its warning. "However, over the years, numerous companies have marketed tests that claim to screen for and detect ovarian cancer," the FDA added. But these tests may lead to delays in effective preventive treatments for high-risk women who have no symptoms, or result in unnecessary medical tests and/or surgery for those who do not have the disease, the agency noted. According to the American Cancer Society, the most common screening test is called the CA-125 blood test. In many women with ovarian cancer, ... Read more

Related support groups: Ovarian Cancer, Diagnosis and Investigation

FDA Medwatch Alert: Ovarian Cancer Screening Tests: Safety Communication - FDA Recommends Against Use

Posted 7 Sep 2016 by Drugs.com

ISSUE: The FDA is alerting women about the risks associated with the use of tests being marketed as ovarian cancer screening tests. The Agency is especially concerned about delaying effective preventive treatments for women who show no symptoms, but who are still at increased risk for developing ovarian cancer. Despite extensive research and published studies, there are currently no screening tests for ovarian cancer that are sensitive enough to reliably screen for ovarian cancer without a high number of inaccurate results. However, over the years, numerous companies have marketed tests that claim to screen for and detect ovarian cancer. FDA is concerned that women and their physicians may be misled by such claims and rely on inaccurate results to make treatment decisions. Based on the FDA’s review of available clinical data from ovarian cancer screening trials and recommendations from h ... Read more

Related support groups: Ovarian Cancer, Diagnosis and Investigation

Are Birth Control Pills Tied to Decline in Ovarian Cancer Deaths?

Posted 7 Sep 2016 by Drugs.com

WEDNESDAY, Sept. 7, 2016 – Ovarian cancer deaths are down dramatically in many parts of the world, and researchers believe the use of birth control pills may be a main reason why. The analysis of World Health Organization data found that the ovarian cancer death rate fell 16 percent in the United States and almost 8 percent in Canada between 2002 and 2012. In the European Union, the ovarian cancer death rate fell 10 percent, though some countries saw far more significant drops. The United Kingdom's ovarian cancer death rate went down by 22 percent. Denmark and Sweden each saw a drop of 24 percent in their death rate from ovarian cancer, the researchers said. Ovarian cancer deaths also decreased about 12 percent in both Australia and New Zealand. In Japan, the ovarian cancer death rate declined 2 percent, the study found. Japan has low rates of birth control use, the researchers said. ... Read more

Related support groups: Birth Control, Contraception, Ovarian Cancer

Use of Cancer-Linked Fibroid Device Declines After FDA Warning

Posted 23 Aug 2016 by Drugs.com

TUESDAY, Aug. 23, 2016 – The use of power morcellators – cutting tools used in minimally invasive gynecological procedures – has dropped significantly for hysterectomies since the U.S. Food and Drug Administration warned against their use two years ago, a new study finds. Power morcellators have small blades that rotate rapidly. When used in minimally invasive hysterectomies or for the removal of noncancerous growths on the uterus known as fibroids, they slice the tissue into smaller pieces that are removed through a small opening in the abdomen. But tiny pieces of tissue can also spread to other areas of the body. And, sometimes, undetected cancers can be cut up with the healthy tissue. If that cancerous tissue isn't completely removed, those cells can cause cancer elsewhere. That's what prompted the FDA to issue its 2014 warning, the researchers explained. The new study looked only ... Read more

Related support groups: Surgery, Cancer, Hysterectomy, Ovarian Cancer, Uterine Leiomyomata / Fibroids, Genitourinary Surgical and Other Conditions, Urinary Tract Cancer

Page 1 2 3 ... Next

Ask a Question

Further Information

Related Condition Support Groups

Cancer

Related Drug Support Groups

methotrexate, Avastin, Taxol, carboplatin, cisplatin, Cytoxan, cyclophosphamide, paclitaxel, Gemzar, view more... Adriamycin, gemcitabine, doxorubicin, Hycamtin, bevacizumab, etoposide, topotecan, amifostine, Lynparza, Platinol, Alkeran, Doxil, olaparib, Hexalen, thiotepa, melphalan, Rubraca, Tepadina, Cytoxan Lyophilized, Adriamycin RDF, Adriamycin PFS, Platinol-AQ, Carboplatin Novaplus, Thioplex, Neosar, Ethyol, rucaparib, doxorubicin liposomal, dactinomycin, Paraplatin, altretamine, Toposar, Etopophos, VePesid, Cosmegen, Onxol